apixaban
Showing 51 - 75 of 153
NOACs in Oral and Maxillofacial Surgery: Impact on
Recruiting
- Surgery, Oral
- +5 more
- Type of surgery
- +5 more
-
Helsingborg, Sweden
- +1 more
Apr 11, 2022
Anticoagulation Strategies for Acute Venous Thromboembolism in
Completed
- Venous Thromboembolic Disease
- Kidney Failure, Chronic
- Warfarin
- Apixaban
-
Baltimore, MarylandJohns Hopkins University
Jul 22, 2021
Covid19 Trial in Cambridge (Apixaban, Atorvastatin)
Recruiting
- Covid19
- Apixaban
- Atorvastatin
-
Cambridge, United KingdomAddenbrookes Hospital
Jul 19, 2021
Heart Failure, Sinus Rhythm, Cerebrovascular Disease Trial in Korea, Republic of (Apixaban, Placebo)
Not yet recruiting
- Heart Failure
- +2 more
- Apixaban
- Placebo
-
Seoul, Guro-gu, Korea, Republic of
- +9 more
Jan 15, 2021
Healthy Trial in Secaucus (Ciraparantag, Placebo, Apixaban)
Completed
- Healthy
- Ciraparantag
- +2 more
-
Secaucus, New JerseyFrontage Clinical Services Inc.
Sep 1, 2020
Anticoagulants; Increased Trial (Apixaban)
Not yet recruiting
- Anticoagulants; Increased
- Apixaban
- (no location specified)
May 14, 2021
Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)
Recruiting
- Coagulation Disorder
- VMX-C001
- +4 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Dec 7, 2021
Non-Vitamin K Oral Anticoagulants in Older Atrial Fibrillation
Active, not recruiting
- Atrial Fibrillation
- +3 more
- Warfarin
- +4 more
-
Boston, MassachusettsBrigham and Women's Hospital
May 5, 2021
Replication of AMPLIFY Anticoagulant Trial in Healthcare Claims
Active, not recruiting
- Venous Thromboembolism
- Apixaban
- Warfarin
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 2, 2021
Atrial Fibrillation (AF) Trial in Worldwide (BAY2433334, Apixaban, BAY2433334 matching )
Completed
- Atrial Fibrillation (AF)
- BAY2433334
- +3 more
-
Braunau, Oberösterreich, Austria
- +92 more
Oct 12, 2021
Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)
Not yet recruiting
- Anticoagulant-induced Bleeding
- Warfarin
- +4 more
-
Quebec, CanadaInstitut Universitaire de Cardiologie et de Pneumologie de Quebe
Feb 17, 2021
Apixaban in NVAF History of Osteoporosis and/or Fracture: A
Withdrawn
- Atrial Fibrillation
- warfarin
- apixaban
-
Seoul, Korea, Republic ofPfizer Investigational Site
May 28, 2020
Renal Insufficiency Trial in France (Apixaban, Rivaroxaban, Heparin)
Active, not recruiting
- Renal Insufficiency
- Apixaban
- +3 more
-
Arras, Boulevard Georges Besnier, France
- +30 more
Feb 2, 2022
Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral
Completed
- Atrial Fibrillation
- Phenprocoumon
- +3 more
-
Multiple Locations, GermanyMany Locations
Nov 24, 2020
Replication of ARISTOTLE Anticoagulant Trial in Healthcare
Unknown status
- Atrial Fibrillation
- Warfarin
- Apixaban
-
Boston, MassachusettsBrigham And Women's Hospital
Oct 13, 2020
Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)
Completed
- Lymphoma
- Acute Lymphoblastic Leukemia
- Apixaban
- No systemic anticoagulant prophylaxis
-
Phoenix, Arizona
- +95 more
Feb 10, 2022
Acute Ischemic Stroke Trial in Cypress (LT3001 drug product, Placebo, Aspirin)
Recruiting
- Acute Ischemic Stroke
- LT3001 drug product
- +5 more
-
Cypress, CaliforniaLumosa Phase 1 Unit
Mar 17, 2021
Vaso-occlusive Crisis, Reduction in Hospitalizations, Sickle Cell Disease Trial in Durham (Apixaban, Placebo)
Terminated
- Vaso-occlusive Crisis
- +2 more
- Apixaban
- Placebo
-
Durham, North CarolinaDuke University Medical Center
Feb 27, 2020
Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement Trial in Worldwide (Apixaban, Standard of care)
Completed
- Symptomatic Aortic Stenosis
- Eligible for Transcatheter Aortic Valve Replacement
- Apixaban
- Standard of care
-
Paris, France
- +3 more
Feb 24, 2021
Spinal Cord Injuries, Venous Thromboembolism Trial in Hamilton (Apixaban, Low molecular weight heparin)
Terminated
- Spinal Cord Injuries
- Venous Thromboembolism
- Apixaban
- Low molecular weight heparin
-
Hamilton, Ontario, CanadaHamilton General Hospital
Feb 18, 2020
Ischemic Stroke, Transient Ischemic Attack, Atrial Fibrillation Trial in Edmonton (Apixaban)
Completed
- Ischemic Stroke
- +2 more
- Apixaban
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 17, 2020